Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Number of shares of common stock	Common stock and additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2022		534.0
Beginning balance at Dec. 31, 2022	$ 3,661		$ 32,514	$ (28,622)	$ (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	2,841			2,841
Other comprehensive income (loss), net of taxes	(37)				(37)
Dividends declared on common stock	(1,138)			(1,138)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.3
Issuance of common stock in connection with the Company’s equity award programs	11		11
Stock-based compensation expense	47		47
Tax impact related to employee stock-based compensation expense	(37)		(37)
Ending balance (in shares) at Mar. 31, 2023		534.3
Ending balance at Mar. 31, 2023	$ 5,348		32,535	(26,919)	(268)
Beginning balance (in shares) at Dec. 31, 2023	535.4	535.4
Beginning balance at Dec. 31, 2023	$ 6,232		33,070	(26,549)	(289)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(113)			(113)
Other comprehensive income (loss), net of taxes	99				99
Dividends declared on common stock	(1,208)			(1,208)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		1.0
Issuance of common stock in connection with the Company’s equity award programs	34		34
Stock-based compensation expense	103		103
Tax impact related to employee stock-based compensation expense	$ (125)		(125)
Ending balance (in shares) at Mar. 31, 2024	536.4	536.4
Ending balance at Mar. 31, 2024	$ 5,022		$ 33,082	$ (27,870)	$ (190)